LATS1 and hepatocellular carcinoma: With markedly lower expression in hepatocellular carcinoma, miR-29c-3p can inhibit tumors by targeting DNA methyltransferase 3B (DNMT3B) and the Hippo signaling pathway involving large tumor suppressor kinase 1 (LATS1) [11].